BNP Paribas Financial Markets
EVMN

BNP Paribas Financial Markets’s Evommune Inc EVMN Stock Holding History

BNP Paribas Financial Markets’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
133,350
+131,150
+5,961% +$3.05M ﹤0.01% 2893
2026
Q1 		$50.6K Buy
+2,200
New +$49.7K ﹤0.01% 4688

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BNP Paribas Financial Markets's EVMN Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Evommune Inc (EVMN) stake by 5,961% in Q2 2026, buying an estimated $3.05M and bringing the position to 133,350 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2893.

BNP Paribas Financial Markets first reported a position in EVMN in Q1 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • BNP Paribas Financial Markets held 133,350 shares of Evommune Inc worth $1.77M as of Q2 2026.
  • BNP Paribas Financial Markets bought 131,150 Evommune Inc shares in Q2 2026, an estimated $3.05M.
  • Evommune Inc made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2893 holding.
  • BNP Paribas Financial Markets first reported a position in Evommune Inc in Q1 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.